{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:25:18Z","timestamp":1789190718073,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00105-023-05145-2","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:02:17Z","timestamp":1682078537000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infantile H\u00e4mangiome","Infantile hemangioma"],"prefix":"10.1007","volume":"74","author":[{"given":"Peter H.","family":"H\u00f6ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"5145_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e8-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e8-Labr\u00e8ze\u00a0C, Harper\u00a0JI, Hoeger\u00a0PH (2017) Infantile Haemangioma. Lancet 390:85\u201394","journal-title":"Lancet"},{"key":"5145_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/pde.13659","volume":"35","author":"JJ Schoch","year":"2018","unstructured":"Schoch\u00a0JJ, Hunjan\u00a0MK, Anderson\u00a0KR et\u00a0al (2018) Temporal trends in prenatal risk factors for the development of infantile hemangiomas. Pediatr Dermatol 35:787\u2013791","journal-title":"Pediatr Dermatol"},{"key":"5145_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","volume":"153","author":"BA Drolet","year":"2008","unstructured":"Drolet\u00a0BA, Swanson\u00a0EA, Frieden\u00a0IJ, Hemangioma Investigator Group (2008) Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J\u00a0Pediatr 153:712\u2013715","journal-title":"J Pediatr"},{"key":"5145_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00403-016-1635-x","volume":"308","author":"S de Jong","year":"2016","unstructured":"de Jong\u00a0S, Itinteang\u00a0T, Withers\u00a0AH et\u00a0al (2016) Does hypoxia play a\u00a0role in infantile hemangioma? Arch Dermatol Res 308:219\u2013227","journal-title":"Arch Dermatol Res"},{"key":"5145_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/bdr2.1023","volume":"109","author":"CJF Smith","year":"2017","unstructured":"Smith\u00a0CJF, Friedlander\u00a0SF, Gurna\u00a0M et\u00a0al (2017) Infantile hemangiomas: an updated review on risk factors, pathogenesis and treatment. Birth Defects Res 109:809\u2013881","journal-title":"Birth Defects Res"},{"key":"5145_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2133.2009.09493.x","volume":"162","author":"V Colonna","year":"2010","unstructured":"Colonna\u00a0V, Resta\u00a0L, Napoli\u00a0A, Bonifazi\u00a0E (2010) Placental hypoxia and neonatal haemangioma: clinical and histological observations. Br J Dermatol 162:208\u2013209","journal-title":"Br J Dermatol"},{"key":"5145_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1542\/peds.2005-1092","volume":"117","author":"AN Haggstrom","year":"2006","unstructured":"Haggstrom\u00a0AN, Lammer\u00a0EJ, Schneider\u00a0RA, Marcucio\u00a0R, Frieden\u00a0IJ (2006) Patterns of infantile hemangioma: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117:698\u2013703","journal-title":"Pediatrics"},{"key":"5145_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/pde.13626","volume":"35","author":"AN Haggstrom","year":"2018","unstructured":"Haggstrom\u00a0AN, Baselga\u00a0E, Chamlin\u00a0SL et\u00a0al (2018) Localized infantile hemangiomas of the face and scalp: predilection for the midline and periorbital and perioral skin. Pediatr Dermatol 35:774\u2013779","journal-title":"Pediatr Dermatol"},{"key":"5145_CR9","volume-title":"Kinderdermatologie","author":"P H\u00f6ger","year":"2021","unstructured":"H\u00f6ger\u00a0P (2021) Kinderdermatologie, 4.\u00a0Aufl. Thieme, Stuttgart","edition":"4"},{"key":"5145_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jaad.2018.07.061","volume":"80","author":"KF O\u2019Brien","year":"2019","unstructured":"O\u2019Brien\u00a0KF, Shah\u00a0SD, Pope\u00a0E et\u00a0al (2019) Late growth of infantile hemangiomas in children \u30093 years of age: a retrospective study. J\u00a0Am Acad Dermatol 80:493\u2013449","journal-title":"J Am Acad Dermatol"},{"key":"5145_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/SAP.0000000000002835","volume":"88","author":"Y Sun","year":"2022","unstructured":"Sun\u00a0Y, Qiu\u00a0F, Hu\u00a0C et\u00a0al (2022) Hemangioma endothelial cells and hemangioma stem cells in infantile hemangioma. Ann Plast Surg 88:244\u2013249","journal-title":"Ann Plast Surg"},{"key":"5145_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/pde.12956","volume":"33","author":"A Reimer","year":"2016","unstructured":"Reimer\u00a0A, Hoeger\u00a0PH (2016) Lesion morphology in multifocal infantile hemangiomas. Pediatr Dermatol 33:621\u2013626","journal-title":"Pediatr Dermatol"},{"key":"5145_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jaad.2020.11.062","volume":"84","author":"Y Ji","year":"2021","unstructured":"Ji\u00a0Y, al Chen Ket\u00a0SY (2021) Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: a multicenter prospective study. J\u00a0Am Acad Dermatol 84:1378\u20131384","journal-title":"J Am Acad Dermatol"},{"key":"5145_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jpedsurg.2014.09.056","volume":"50","author":"KL Rialon","year":"2015","unstructured":"Rialon\u00a0KL, Murillo\u00a0R, Fevurly\u00a0RD et\u00a0al (2015) Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J\u00a0Pediatr Surg 50:837\u2013841","journal-title":"J Pediatr Surg"},{"key":"5145_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/pde.13695","volume":"36","author":"JM Martin","year":"2019","unstructured":"Martin\u00a0JM, Sanchez\u00a0S, Gonz\u00e1lez\u00a0V et\u00a0al (2019) Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Pediatr Dermatol 36:125\u2013131","journal-title":"Pediatr Dermatol"},{"key":"5145_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jaad.2015.01.028","volume":"72","author":"D Bessis","year":"2015","unstructured":"Bessis\u00a0D, Bigorre\u00a0M, Labr\u00e8ze\u00a0C (2015) Reticular infantile hemangiomas with minimal or arrested growth associated with lipoatrophy. J\u00a0Am Acad Dermatol 72:828\u2013833","journal-title":"J Am Acad Dermatol"},{"key":"5145_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaad.2016.03.029","volume":"75","author":"A Reimer","year":"2016","unstructured":"Reimer\u00a0A, Fliesser\u00a0M, Hoeger\u00a0PH (2016) Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). J\u00a0Am Acad Dermatol 75:556\u2013563","journal-title":"J Am Acad Dermatol"},{"key":"5145_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.12788\/j.sder.2016.047","volume":"35","author":"M Luu","year":"2016","unstructured":"Luu\u00a0M, Frieden\u00a0IJ (2016) Infantile hemangiomas and structural anomalies: PHACE and LUMBAR syndrome. Semin Cutan Med Surg 35:117\u2013123","journal-title":"Semin Cutan Med Surg"},{"key":"5145_CR19","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/bjd.18246","volume":"181","author":"F Schmid","year":"2019","unstructured":"Schmid\u00a0F, Reipschlaeger\u00a0M, Leenen\u00a0A, Hoeger\u00a0PH (2019) Risk of associated cerebrovascular anomalies in children with segmental facial haemangiomas. Br J Dermatol 181:1334\u20131335","journal-title":"Br J Dermatol"},{"key":"5145_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2016.07.054","volume":"178","author":"MC Garzon","year":"2016","unstructured":"Garzon\u00a0MC, Epstein\u00a0LG, Heyer\u00a0GL et al (2016) PHACE syndrome: consensus-derived diagnosis and care recommendations. J\u00a0Pediatr 178:24\u201333.e2","journal-title":"J Pediatr"},{"key":"5145_CR21","unstructured":"Arbeitsgemeinschaft der wissenschaftlichen medizinischen Fachgesellschaften (AWMF). S2k-Leitlinie Infantile H\u00e4mangiome im S\u00e4uglings- und Kleinkindesalter. Reg.-Nr.\u00a0006-100, g\u00fcltig bis 31. Okt. 2023"},{"key":"5145_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","volume":"163","author":"CH Storch","year":"2010","unstructured":"Storch\u00a0CH, Hoeger\u00a0PH (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269\u2013274","journal-title":"Br J Dermatol"},{"key":"5145_CR23","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/SAP.0000000000002104","volume":"83","author":"HH Li","year":"2019","unstructured":"Li\u00a0HH, Lou\u00a0Y, Zhang\u00a0RR et\u00a0al (2019) Propranolol accelerates Hemangioma stem cell transformation into adipocyte. Ann Plast Surg 83:e5\u2013e13","journal-title":"Ann Plast Surg"},{"key":"5145_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze\u00a0C, Hoeger\u00a0P, Mazereeuw-Hautier\u00a0J et al (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N\u00a0Engl J Med 372:735\u2013746","journal-title":"N Engl J Med"},{"key":"5145_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/bjd.14233","volume":"174","author":"E Wedgeworth","year":"2016","unstructured":"Wedgeworth\u00a0E, Glover\u00a0M, Irvine\u00a0AD et\u00a0al (2016) Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. Br J Dermatol 174:594\u2013601","journal-title":"Br J Dermatol"},{"key":"5145_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/pde.12681","volume":"32","author":"M Hengst","year":"2015","unstructured":"Hengst\u00a0M, Oelert\u00a0M, Hoeger\u00a0PH (2015) Blood pressure monitoring during the induction and maintendance period of propranolol therapy for complicated infantile hemangiomas: a prospective study of 109 infants. Pediatr Dermatol 32:802\u2013807","journal-title":"Pediatr Dermatol"},{"key":"5145_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2021.10.054","volume":"87","author":"F Schmid","year":"2022","unstructured":"Schmid\u00a0F, Hoeger\u00a0PH (2022) Propranolol response in patients with segmental versus focal facial hemangiomas: a retrospective case-control study. J\u00a0Am Acad Dermatol 87:490\u2013491","journal-title":"J Am Acad Dermatol"},{"key":"5145_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/pde.13177","volume":"34","author":"CB Bayart","year":"2017","unstructured":"Bayart\u00a0CB, Tamburro\u00a0JE, Vidimos\u00a0AT et\u00a0al (2017) Atenolol versus propranolol for treatment of infantile Hemangiomas during the proliferative phase: a retrospective noninferiority study. Pediatr Dermatol 34:413\u2013421","journal-title":"Pediatr Dermatol"},{"key":"5145_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/pde.12686","volume":"32","author":"J Bernabeu-Wittel","year":"2015","unstructured":"Bernabeu-Wittel\u00a0J, Narv\u00e1ez-Moreno\u00a0B, de la Torre-Garc\u00eda\u00a0JM et al (2015) Oral nadolol for children with infantile Hemangiomas and sleep disturbances with oral propranolol. Pediatr Dermatol 32:853\u2013857","journal-title":"Pediatr Dermatol"},{"key":"5145_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/pde.12869","volume":"33","author":"P Frommelt","year":"2016","unstructured":"Frommelt\u00a0P, Juern\u00a0A, Siegel\u00a0D et\u00a0al (2016) Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma. Pediatr Dermatol 33:405\u2013414","journal-title":"Pediatr Dermatol"},{"key":"5145_CR31","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1111\/bjd.15865","volume":"178","author":"J Borok","year":"2018","unstructured":"Borok\u00a0J, Gangar\u00a0P, Admani\u00a0S et\u00a0al (2018) Safety and efficacy of topical timolol treatment of infantile haemangioma: a\u00a0prospective trial. Br J Dermatol 178:e51\u2013e52","journal-title":"Br J Dermatol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05145-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05145-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05145-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:23:43Z","timestamp":1683768223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05145-2"}},"subtitle":["Manifestationsformen, Therapie, Differenzialdiagnosen","Clinical manifestation, treatment, and differential diagnoses"],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5145"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05145-2","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"21 April 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.H.\u00a0H\u00f6ger hat Honorare f\u00fcr Beratert\u00e4tigkeiten, Vortr\u00e4ge und die Durchf\u00fchrung von Studien von folgenden Pharmaunternehmen erhalten: 1.\u00a0Unterst\u00fctzung klinischer Forschung: AbbVie, Lilly, Mayne, Novartis; 2.\u00a0Beratung: AbbVie, Novartis, Klinge, Golin; 3.\u00a0Vortragshonorare: Thieme Verlag, Novartis, Beiersdorf. H.\u00a0Hamm hat Honorare f\u00fcr Beratert\u00e4tigkeiten, Vortr\u00e4ge und die Durchf\u00fchrung von Studien von folgenden Pharmaunternehmen erhalten: Allergika, Biogen, InfectoPharm, Lilly, Novartis, Pierre Fabre Dermo Kosmetik.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}